Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: Incidence, characteristics, and risk factors

Heart Rhythm

Volumn 11, Issue 11, 2014, Pages 1934-1940

  Kosiuk, Jedrzej ^a   Kornej, Jelena ^a,b   Bollmann, Andreas ^a   Piorkowski, Christopher ^c   Myrda, Krzysztof ^d   Arya, Arash ^a   Sommer, Philipp ^a   Richter, Sergio ^a   Rolf, Sascha ^a   Husser, Daniela ^a   Gaspar, Thomas ^c   Lip, Gregory Y H ^b   Hindricks, Gerhard ^a  

^a UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Atrial fibrillation; Catheter ablation; Complications; Thromboembolism

Indexed keywords

ENOXAPARIN;

ABLATION CATHETER; ADULT; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; BRAIN EMBOLISM; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CATHETER ABLATION; CHADS2 SCORE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RESTING HEART RATE; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; INTRACRANIAL THROMBOSIS; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RISK FACTOR;

ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; HUMANS; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 84911468622     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2014.07.039     Document Type: Article

References (23)

1. Calkins, H., Catheter ablation to maintain sinus rhythm. Circulation 125 (2012), 1439–1445.
2. Cappato, R., Calkins, H., Chen, S.A., Davies, W., Iesaka, Y., Kalman, J., Kim, Y.H., Klein, G., Packer, D., Skanes, A., Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 111 (2005), 1100–1105.
3. Cappato, R., Calkins, H., Chen, S.A., et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 3 (2010), 32–38.
4. Lang, R.M., Bierig, M., Devereux, R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005), 1440–1463.
5. Gage, B.F., Waterman, A.D., Shannon, W., Boechler, M., Rich, M.W., Radford, M.J., Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285 (2001), 2864–2870.
6. Lip, G.Y., Nieuwlaat, R., Pisters, R., Lane, D.A., Crijns, H.J., Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest 137 (2010), 263–272.
7. Eitel, C., Hindricks, G., Sommer, P., et al. Circumferential pulmonary vein isolation and linear left atrial ablation as a single-catheter technique to achieve bidirectional conduction block: the pace-and-ablate approach. Heart Rhythm 7 (2010), 157–164.
8. Puwanant, S., Varr, B.C., Shrestha, K., Hussain, S.K., Tang, W.H., Gabriel, R.S., Wazni, O.M., Bhargava, M., Saliba, W.I., Thomas, J.D., Lindsay, B.D., Klein, A.L., Role of the CHADS2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation. J Am Coll Cardiol 54 (2009), 2032–2039.
9. McCready, J.W., Nunn, L., Lambiase, P.D., Ahsan, S.Y., Segal, O.R., Rowland, E., Lowe, M.D., Chow, A.W., Incidence of left atrial thrombus prior to atrial fibrillation ablation: is pre-procedural transoesophageal echocardiography mandatory?. Europace 12 (2010), 927–932.
10. Rathi, V.K., Reddy, S.T., Anreddy, S., Belden, W., Yamrozik, J.A., Williams, R.B., Doyle, M., Thompson, D.V., Biederman, R.W., Contrast-enhanced CMR is equally effective as TEE in the evaluation of left atrial appendage thrombus in patients with atrial fibrillation undergoing pulmonary vein isolation procedure. Heart Rhythm 10 (2013), 1021–1027.
11. Kim, J.S., Jongnarangsin, K., Latchamsetty, R., Chugh, A., Ghanbari, H., Crawford, T., Yokokawa, M., Good, E., Bogun, F., Pelosi, F. Jr, Morady, F., Oral, H., The optimal range of international normalized ratio for radiofrequency catheter ablation of atrial fibrillation during therapeutic anticoagulation with warfarin. Circ Arrhythm Electrophysiol 6 (2013), 302–309.
12. Kuwahara, T., Takahashi, A., Takahashi, Y., et al. Prevention of periprocedural ischemic stroke and management of hemorrhagic complications in atrial fibrillation ablation under continuous warfarin administration. J Cardiovasc Electrophysiol 24 (2013), 510–515.
13. Di Biase, L., Burkhardt, J.D., Mohanty, P., et al. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the “COMPARE” randomized trial. Circulation 129 (2014), 2638–2644.
14. Duytschaever, M., Berte, B., Acena, M., DE Meyer, G., Bun, S.S., VAN Heuverswyn, F., Vandekerckhove, Y., Tavernier, R., Catheter ablation of atrial fibrillation in patients at low thrombo-embolic risk: efficacy and safety of a simplified periprocedural anticoagulation strategy. J Cardiovasc Electrophysiol 24 (2013), 855–860.
15. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P, ESC Committee for Practice Guidelines-CPG; Document Reviewers. Focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Europace 2012;14:1385–1413.
16. Patel, D., Bailey, S.M., Furlan, A.J., et al. Long-term functional and neurocognitive recovery in patients who had an acute cerebrovascular event secondary to catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol 21 (2010), 412–417.
17. Lin, L.Y., Lee, C.H., Yu, C.C., Tsai, C.T., Lai, L.P., Hwang, J.J., Chen, P.C., Lin, J.L., Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial fibrillation: a nationwide database analysis. Atherosclerosis 217 (2011), 292–295.
18. Olesen, J.B., Lip, G.Y., Lane, D.A., Køber, L., Hansen, M.L., Karasoy, D., Hansen, C.M., Gislason, G.H., Torp-Pedersen, C., Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study. Am J Med 125 (2012), 13–23.
19. Anandasundaram, B., Lane, D.A., Apostolakis, S., Lip, G.Y., The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review. J Thromb Haemost 11 (2013), 975–987.
20. Rajagopalan, S., Mckay, I., Ford, I., Bachoo, P., Greaves, M., Brittenden, J., Platelet activation increases with the severity of peripheral arterial disease: implications for clinical management. J Vasc Surg 46 (2007), 485–490.
21. Lim, H.S., Willoughby, S.R., Schultz, C., et al. Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. J Am Coll Cardiol 61 (2013), 852–860.
22. Chao, T.F., Lin, Y.J., Tsao, H.M., et al. CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation. J Am Coll Cardiol 58 (2011), 2380–2385.
23. Schmidt, B., Gunawardene, M., Krieg, D., Bordignon, S., Fürnkranz, A., Kulikoglu, M., Herrmann, W., Chun, K.R., A prospective randomized single-center study on the risk of asymptomatic cerebral lesions comparing irrigated radiofrequency current ablation with the cryoballoon and the laser balloon. J Cardiovasc Electrophysiol 24 (2013), 869–874.